Cornell University - S.C. Johnson Graduate School of Management
MBA
2006
Technical University Munich
Ph.D. (Molecular Pharmacology)
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Master's degree (Pharmacology)
Nanjing University
B.S. (Life Science)
Caroline Xu's Skills
Pharmaceutical Industry
Oncology
Biotechnology
Sales Effectiveness
Drug Development
Product Launch
Strategy
Commercialization
Biopharmaceuticals
Drug Discovery
Caroline Xu's Summary
Caroline Xu, based in Munich, BY, DE, is currently a Global Director New Products and Portfolio Strategy, Sandoz BioPharmaceuticals at Novartis, bringing experience from previous roles at ViGeneron GmbH, a Next Generation Gene Therapy Company, Novartis, Novartis Oncology and Novartis Pharma AG. Caroline Xu holds a MBA @ Cornell University - S.C. Johnson Graduate School of Management. With a robust skill set that includes Pharmaceutical Industry, Oncology, Biotechnology, Sales Effectiveness, Drug Development and more, Caroline Xu contributes valuable insights to the industry. Caroline Xu has 3 emails on RocketReach.